PMID: 42210941

Sequential CDK4/6 inhibition in bone-only metastatic HR+/HER2- breast cancer: a case of prolonged disease control with abemaciclib after clinical progression on palbociclib-based therapy.

Peng Xuejiao, Chang Weiqin

Frontiers in medicine · 2026

Vol. 13, pp. 1775724

View on PubMedDOI

This entry links to third-party literature. For research use only.

For research use only. This index links to third-party literature. Nothing here constitutes medical advice.